lact c2 gfp 14 Search Results


95
Addgene inc gfp lact c2 fusion protein
Gfp Lact C2 Fusion Protein, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gfp lact c2 fusion protein/product/Addgene inc
Average 95 stars, based on 1 article reviews
gfp lact c2 fusion protein - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

93
Addgene inc lact c2 gfp
Lact C2 Gfp, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lact c2 gfp/product/Addgene inc
Average 93 stars, based on 1 article reviews
lact c2 gfp - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

90
Addgene inc lact c2 gfp 14
Lact C2 Gfp 14, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lact c2 gfp 14/product/Addgene inc
Average 90 stars, based on 1 article reviews
lact c2 gfp 14 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Addgene inc lact-c2-gfp
Lact C2 Gfp, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lact-c2-gfp/product/Addgene inc
Average 90 stars, based on 1 article reviews
lact-c2-gfp - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

93
Addgene inc pkcɣ c1a dag gfp c1 pkcgamma c1a
Pkcɣ C1a Dag Gfp C1 Pkcgamma C1a, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pkcɣ c1a dag gfp c1 pkcgamma c1a/product/Addgene inc
Average 93 stars, based on 1 article reviews
pkcɣ c1a dag gfp c1 pkcgamma c1a - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

90
Takeda gfp-lact-c2-aaa
Saccharomyces cerevisiae strains used in this study
Gfp Lact C2 Aaa, supplied by Takeda, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gfp-lact-c2-aaa/product/Takeda
Average 90 stars, based on 1 article reviews
gfp-lact-c2-aaa - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

92
Addgene inc metabolite sensors
Saccharomyces cerevisiae strains used in this study
Metabolite Sensors, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/metabolite sensors/product/Addgene inc
Average 92 stars, based on 1 article reviews
metabolite sensors - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

90
Haematologic Technologies plasmid gfp-lact-c2
Saccharomyces cerevisiae strains used in this study
Plasmid Gfp Lact C2, supplied by Haematologic Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/plasmid gfp-lact-c2/product/Haematologic Technologies
Average 90 stars, based on 1 article reviews
plasmid gfp-lact-c2 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier



93
Addgene inc fluorescent protein gfp lactadherin lact c2 fusion protein
Measurements of ANO6 Ca 2+ -activated ion channel and phospholipid scramblase activities (A–C) The inhibitory effect of A6-001 on the ANO6 ion channel activity was analyzed using a whole-cell patch clamp in HEK 293T cells expressing ANO6. The pipette solution contained 10 μM free Ca 2+ . Voltage ramps spanning a range of −100 to +100 mV were delivered from a holding potential of −60 mV every 20 s (A). The current-voltage (I-V) relationships at indicated times (1–5) with increasing concentrations of A6-001 are shown in (B). The numbers in parentheses represent the time points to measure I-V relationships. The inward currents in (A) represent ANO6 tail currents. The half-maximal inhibitory concentration (IC 50 ) of A6-001 on the ANO6 ion channel activity is depicted in (C) (n = 4 at each concentration). (D–F) The effects of ANO6 inhibitors on the surface exposure of phosphatidylserine (PS) were assayed in FRT-ANO6 cells. Cells were pretreated with compounds for 10 min, before ANO6 was activated with 10 μM ionomycin. Exposed PS was stained with <t>Lact-C2-GFP.</t> Representative fluorescence images of A6-001 (10 μM), A6-004 (10 μM), abamectin (10 μM), and ivermectin (10 μM) are shown in (D) (scale bars: 10 μm), and fluorescence intensity values calculated from Lact-C2-GFP images are summarized in (E) (mean ± SEM; n = 6). The dose responses of A6-001 on ANO6 PS scramblase inhibition are analyzed in (F) (mean ± SEM; n = 6). Representative fluorescence images of A6-001 dose response are shown in <xref ref-type=Figure S2 H. (G and H) The inhibitory effect of A6-001 on PS scrambling was assayed using the four-quadrant dot blot FACS analysis in Jurkat cells, some of which were transfected with hANO6-expressing plasmids using a NEPA21 Super Electroporator (Jurkat-ANO6). Ionomycin evoked an increase in the Lact-C2-positive and propidium iodide (PI)-negative cell population (Q3), which represented the PS-exposed and non-apoptotic cells, respectively. The ionomycin-induced Q3 increase was augmented considerably in cells expressing exogenous ANO6. A6-001 (10 μM) reversed the Q3 increases in Jurkat and Jurkat-ANO6 cells. Representative FACS analyses are shown in (G), and a summary of the multiple experiments is presented in (H) (mean ± SEM; n = 5). ∗ p < 0.05 and ∗∗ p < 0.01: differences from lane 2. Data were analyzed using one-way analysis of variance, followed by Tukey’s multiple comparison test. See also Figure S2 . " width="250" height="auto" />
Fluorescent Protein Gfp Lactadherin Lact C2 Fusion Protein, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fluorescent protein gfp lactadherin lact c2 fusion protein/product/Addgene inc
Average 93 stars, based on 1 article reviews
fluorescent protein gfp lactadherin lact c2 fusion protein - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier


Image Search Results


Saccharomyces cerevisiae strains used in this study

Journal: MicrobiologyOpen

Article Title: Asymmetric distribution of phosphatidylserine is generated in the absence of phospholipid flippases in Saccharomyces cerevisiae

doi: 10.1002/mbo3.211

Figure Lengend Snippet: Saccharomyces cerevisiae strains used in this study

Article Snippet: pKT1995 [pRS306-GFP-Lact-C2-AAA] , GFP-Lact-C2-AAA URA3 , Takeda et al. ( ) .

Techniques:

Plasmids used in this study

Journal: MicrobiologyOpen

Article Title: Asymmetric distribution of phosphatidylserine is generated in the absence of phospholipid flippases in Saccharomyces cerevisiae

doi: 10.1002/mbo3.211

Figure Lengend Snippet: Plasmids used in this study

Article Snippet: pKT1995 [pRS306-GFP-Lact-C2-AAA] , GFP-Lact-C2-AAA URA3 , Takeda et al. ( ) .

Techniques:

PS is present on the surface of accumulated SVs and the TGN, but not the ER, in secretory mutant cells. (A) Phenotypes of temperature-sensitive sec and myo2 mutants. (B) Localization of mRFP-Lact-C2 to accumulated SVs and TGN membranes in sec6-4/myo2-12 and sec7-1 cells, respectively. Cells were incubated for 1 h in SD-Leu medium or SD-Leu medium supplemented with 1 mmol/L ethanolamine ( cho1 Δ mutants) or for 2 h in SD-Leu-Ura medium ( myo2-12 mutant) at 30°C (control) or 37°C. The strains used were wild type (WT) (YKT1843), cho1 Δ (YKT1845), sec6-4 (YKT1844), sec6-4 cho1 Δ (YKT1846), myo2-12 (YKT1678), sec7-1 (YKT1857), and sec7-1 cho1 Δ (YKT1858). These strains, all carrying mRFP1-Lact-C2 integrated at the URA3 locus except the myo2-12 mutant, were transformed with pRS315-GFP-SNC1 pm (pKT1491). The myo2-12 mutant was cotransformed with pKT1491 and pRS416-mRFP1-Lact-C2 (pKT1755). Bar, 5 μ m. (C) mRFP-Lact-C2 did not localize to accumulated ER membranes. Cells were incubated for 1 h in SD-Leu-Ura medium at 25°C (control) or 37°C. The strains used were sec12-4 (MBY10-11D), sec21-1 (MBY6-4D), and sec23-1 (MBY8-20C), all cotransformed with pRS315-GFP-SNC1 pm (pKT1491) and pRS416-mRFP1-Lact-C2 (pKT1755). Bar, 5 μ m.

Journal: MicrobiologyOpen

Article Title: Asymmetric distribution of phosphatidylserine is generated in the absence of phospholipid flippases in Saccharomyces cerevisiae

doi: 10.1002/mbo3.211

Figure Lengend Snippet: PS is present on the surface of accumulated SVs and the TGN, but not the ER, in secretory mutant cells. (A) Phenotypes of temperature-sensitive sec and myo2 mutants. (B) Localization of mRFP-Lact-C2 to accumulated SVs and TGN membranes in sec6-4/myo2-12 and sec7-1 cells, respectively. Cells were incubated for 1 h in SD-Leu medium or SD-Leu medium supplemented with 1 mmol/L ethanolamine ( cho1 Δ mutants) or for 2 h in SD-Leu-Ura medium ( myo2-12 mutant) at 30°C (control) or 37°C. The strains used were wild type (WT) (YKT1843), cho1 Δ (YKT1845), sec6-4 (YKT1844), sec6-4 cho1 Δ (YKT1846), myo2-12 (YKT1678), sec7-1 (YKT1857), and sec7-1 cho1 Δ (YKT1858). These strains, all carrying mRFP1-Lact-C2 integrated at the URA3 locus except the myo2-12 mutant, were transformed with pRS315-GFP-SNC1 pm (pKT1491). The myo2-12 mutant was cotransformed with pKT1491 and pRS416-mRFP1-Lact-C2 (pKT1755). Bar, 5 μ m. (C) mRFP-Lact-C2 did not localize to accumulated ER membranes. Cells were incubated for 1 h in SD-Leu-Ura medium at 25°C (control) or 37°C. The strains used were sec12-4 (MBY10-11D), sec21-1 (MBY6-4D), and sec23-1 (MBY8-20C), all cotransformed with pRS315-GFP-SNC1 pm (pKT1491) and pRS416-mRFP1-Lact-C2 (pKT1755). Bar, 5 μ m.

Article Snippet: pKT1995 [pRS306-GFP-Lact-C2-AAA] , GFP-Lact-C2-AAA URA3 , Takeda et al. ( ) .

Techniques: Mutagenesis, Incubation, Control, Transformation Assay

Localization of GFP-Snc1p-pm and mRFP-Lact-C2 in flippase-defective secretory mutant cells. (A) and (B) Localization of GFP-Snc1p-pm and mRFP-Lact-C2 in lem3 Δ crf1 Δ and cdc50 Δ mutants. Cells were incubated in SD-Leu medium at 30°C (control) or 37°C for 1 h. The strains used were lem3 Δ crf1 Δ (YKT1847) , sec6-4 lem3 Δ crf1 Δ (YKT1848) , sec7-1 lem3 Δ crf1 Δ (YKT1860), cdc50 Δ (YKT1849) , sec6-4 cdc50 Δ (YKT1850) , and sec7-1 cdc50 Δ (YKT1859), all carrying URA3::mRFP1-Lact-C2 and pRS315-GFP-SNC1 pm (pKT1491). Bar, 5 μ m. (C) Localization of GFP-Snc1p-pm with Sec7p-mRFP or mRFP-Snc1p in the cdc50 Δ mutant. (Left panel) SEC7-mRFP1 (YKT1670) and cdc50 Δ SEC7-mRFP1 (YKT1149) cells, both carrying pRS416-GFP-SNC1 pm (pKT1444), were incubated in SD-Ura medium at 30°C. (Right panel) Wild-type (YKT38) and cdc50 Δ (YKT249) cells, both carrying pRS416-GFP-SNC1 pm (pKT1444) and pRS315-mRFP1-SNC1 (pKT1568), were incubated in SD-Leu-Ura medium at 30°C. Regions labeled with small characters are twofold enlarged to compare GFP and mRFP signal patterns. Bar, 5 μ m.

Journal: MicrobiologyOpen

Article Title: Asymmetric distribution of phosphatidylserine is generated in the absence of phospholipid flippases in Saccharomyces cerevisiae

doi: 10.1002/mbo3.211

Figure Lengend Snippet: Localization of GFP-Snc1p-pm and mRFP-Lact-C2 in flippase-defective secretory mutant cells. (A) and (B) Localization of GFP-Snc1p-pm and mRFP-Lact-C2 in lem3 Δ crf1 Δ and cdc50 Δ mutants. Cells were incubated in SD-Leu medium at 30°C (control) or 37°C for 1 h. The strains used were lem3 Δ crf1 Δ (YKT1847) , sec6-4 lem3 Δ crf1 Δ (YKT1848) , sec7-1 lem3 Δ crf1 Δ (YKT1860), cdc50 Δ (YKT1849) , sec6-4 cdc50 Δ (YKT1850) , and sec7-1 cdc50 Δ (YKT1859), all carrying URA3::mRFP1-Lact-C2 and pRS315-GFP-SNC1 pm (pKT1491). Bar, 5 μ m. (C) Localization of GFP-Snc1p-pm with Sec7p-mRFP or mRFP-Snc1p in the cdc50 Δ mutant. (Left panel) SEC7-mRFP1 (YKT1670) and cdc50 Δ SEC7-mRFP1 (YKT1149) cells, both carrying pRS416-GFP-SNC1 pm (pKT1444), were incubated in SD-Ura medium at 30°C. (Right panel) Wild-type (YKT38) and cdc50 Δ (YKT249) cells, both carrying pRS416-GFP-SNC1 pm (pKT1444) and pRS315-mRFP1-SNC1 (pKT1568), were incubated in SD-Leu-Ura medium at 30°C. Regions labeled with small characters are twofold enlarged to compare GFP and mRFP signal patterns. Bar, 5 μ m.

Article Snippet: pKT1995 [pRS306-GFP-Lact-C2-AAA] , GFP-Lact-C2-AAA URA3 , Takeda et al. ( ) .

Techniques: Mutagenesis, Incubation, Control, Labeling

Quantitative analysis of PS on isolated LDSVs by measurement of mRFP-Lact-C2 fluorescence intensity. Cells were grown at 30°C or shifted to 37°C for 2 h. LDSVs were isolated from the cells by subcellular fractionation followed by Nycodenz gradient fractionation. Relative fluorescence intensity of mRFP-Lact-C2 was measured using a spectrofluorometer, and total phospholipid phosphates were determined. Pma1p and mRFP-Lact-C2 were detected by Western blotting using antibodies against Pma1p and RFP, respectively. The SV-enriched fraction from sec6-4 cells in (A) was loaded as a positive control (PC) for Western blotting in (C) and (D). The strains used were sec6-4 (YKT1844) (A and D), wild type (WT) (YKT1843) (C), and sec6-4 cho1 Δ (YKT1846) (B), all carrying mRFP1-Lact-C2 at the genomic URA3 locus.

Journal: MicrobiologyOpen

Article Title: Asymmetric distribution of phosphatidylserine is generated in the absence of phospholipid flippases in Saccharomyces cerevisiae

doi: 10.1002/mbo3.211

Figure Lengend Snippet: Quantitative analysis of PS on isolated LDSVs by measurement of mRFP-Lact-C2 fluorescence intensity. Cells were grown at 30°C or shifted to 37°C for 2 h. LDSVs were isolated from the cells by subcellular fractionation followed by Nycodenz gradient fractionation. Relative fluorescence intensity of mRFP-Lact-C2 was measured using a spectrofluorometer, and total phospholipid phosphates were determined. Pma1p and mRFP-Lact-C2 were detected by Western blotting using antibodies against Pma1p and RFP, respectively. The SV-enriched fraction from sec6-4 cells in (A) was loaded as a positive control (PC) for Western blotting in (C) and (D). The strains used were sec6-4 (YKT1844) (A and D), wild type (WT) (YKT1843) (C), and sec6-4 cho1 Δ (YKT1846) (B), all carrying mRFP1-Lact-C2 at the genomic URA3 locus.

Article Snippet: pKT1995 [pRS306-GFP-Lact-C2-AAA] , GFP-Lact-C2-AAA URA3 , Takeda et al. ( ) .

Techniques: Isolation, Fluorescence, Fractionation, Western Blot, Positive Control

Loss of Lem3p/Crf1p or Cdc50p does not decrease the level of PS in the cytosolic face of LDSVs. (A) Fractionation profile of mRFP-Lact-C2 and total phospholipid phosphates in flippase mutants. Cells were grown in YPDA medium at 30°C and shifted to 37°C for 2 h, whereas P GAL1 -3HA-NEO1 sec6-4 cells were incubated in YPDA medium at 30°C for 8.5 h, followed by a shift to 37°C for 2 h. SVs were isolated and fractionated by Nycodenz density gradient as in Figure . The strains used were sec6-4 (YKT1844), sec6-4 cho1 Δ (YKT1846), sec6-4 lem3 Δ crf1 Δ (YKT1848) , sec6-4 cdc50 Δ (YKT1850), and sec6-4 P GAL1 -3HA-NEO1 (YKT1852), all carrying mRFP1-Lact-C2 at the genomic URA3 locus, and sec6-4 (AAA) (YKT1919) carrying mRFP1-Lact-C2-AAA at the genomic URA3 locus. (B) Lact/Phospholipid in the flippase mutants. Lact/Phospholipid was calculated as the ratio of relative fluorescence intensity of mRFP-Lact-C2 to total phospholipid phosphates in the peak and adjacent four fractions. Data shown are means ± SD of three independent experiments. (C) Localization of GFP-Snc1p-pm and mRFP-Lact-C2-AAA. Cells were incubated in SD-Leu medium at 30°C or 37°C for 1 h. The strains used were mRFP1-Lact-C2-AAA (YKT1918) and sec6-4 mRFP1-Lact-C2-AAA (YKT1919), both carrying pRS315-GFP-SNC1 pm (pKT1491). Bar, 5 μ m.

Journal: MicrobiologyOpen

Article Title: Asymmetric distribution of phosphatidylserine is generated in the absence of phospholipid flippases in Saccharomyces cerevisiae

doi: 10.1002/mbo3.211

Figure Lengend Snippet: Loss of Lem3p/Crf1p or Cdc50p does not decrease the level of PS in the cytosolic face of LDSVs. (A) Fractionation profile of mRFP-Lact-C2 and total phospholipid phosphates in flippase mutants. Cells were grown in YPDA medium at 30°C and shifted to 37°C for 2 h, whereas P GAL1 -3HA-NEO1 sec6-4 cells were incubated in YPDA medium at 30°C for 8.5 h, followed by a shift to 37°C for 2 h. SVs were isolated and fractionated by Nycodenz density gradient as in Figure . The strains used were sec6-4 (YKT1844), sec6-4 cho1 Δ (YKT1846), sec6-4 lem3 Δ crf1 Δ (YKT1848) , sec6-4 cdc50 Δ (YKT1850), and sec6-4 P GAL1 -3HA-NEO1 (YKT1852), all carrying mRFP1-Lact-C2 at the genomic URA3 locus, and sec6-4 (AAA) (YKT1919) carrying mRFP1-Lact-C2-AAA at the genomic URA3 locus. (B) Lact/Phospholipid in the flippase mutants. Lact/Phospholipid was calculated as the ratio of relative fluorescence intensity of mRFP-Lact-C2 to total phospholipid phosphates in the peak and adjacent four fractions. Data shown are means ± SD of three independent experiments. (C) Localization of GFP-Snc1p-pm and mRFP-Lact-C2-AAA. Cells were incubated in SD-Leu medium at 30°C or 37°C for 1 h. The strains used were mRFP1-Lact-C2-AAA (YKT1918) and sec6-4 mRFP1-Lact-C2-AAA (YKT1919), both carrying pRS315-GFP-SNC1 pm (pKT1491). Bar, 5 μ m.

Article Snippet: pKT1995 [pRS306-GFP-Lact-C2-AAA] , GFP-Lact-C2-AAA URA3 , Takeda et al. ( ) .

Techniques: Fractionation, Incubation, Isolation, Fluorescence

Measurements of ANO6 Ca 2+ -activated ion channel and phospholipid scramblase activities (A–C) The inhibitory effect of A6-001 on the ANO6 ion channel activity was analyzed using a whole-cell patch clamp in HEK 293T cells expressing ANO6. The pipette solution contained 10 μM free Ca 2+ . Voltage ramps spanning a range of −100 to +100 mV were delivered from a holding potential of −60 mV every 20 s (A). The current-voltage (I-V) relationships at indicated times (1–5) with increasing concentrations of A6-001 are shown in (B). The numbers in parentheses represent the time points to measure I-V relationships. The inward currents in (A) represent ANO6 tail currents. The half-maximal inhibitory concentration (IC 50 ) of A6-001 on the ANO6 ion channel activity is depicted in (C) (n = 4 at each concentration). (D–F) The effects of ANO6 inhibitors on the surface exposure of phosphatidylserine (PS) were assayed in FRT-ANO6 cells. Cells were pretreated with compounds for 10 min, before ANO6 was activated with 10 μM ionomycin. Exposed PS was stained with Lact-C2-GFP. Representative fluorescence images of A6-001 (10 μM), A6-004 (10 μM), abamectin (10 μM), and ivermectin (10 μM) are shown in (D) (scale bars: 10 μm), and fluorescence intensity values calculated from Lact-C2-GFP images are summarized in (E) (mean ± SEM; n = 6). The dose responses of A6-001 on ANO6 PS scramblase inhibition are analyzed in (F) (mean ± SEM; n = 6). Representative fluorescence images of A6-001 dose response are shown in <xref ref-type=Figure S2 H. (G and H) The inhibitory effect of A6-001 on PS scrambling was assayed using the four-quadrant dot blot FACS analysis in Jurkat cells, some of which were transfected with hANO6-expressing plasmids using a NEPA21 Super Electroporator (Jurkat-ANO6). Ionomycin evoked an increase in the Lact-C2-positive and propidium iodide (PI)-negative cell population (Q3), which represented the PS-exposed and non-apoptotic cells, respectively. The ionomycin-induced Q3 increase was augmented considerably in cells expressing exogenous ANO6. A6-001 (10 μM) reversed the Q3 increases in Jurkat and Jurkat-ANO6 cells. Representative FACS analyses are shown in (G), and a summary of the multiple experiments is presented in (H) (mean ± SEM; n = 5). ∗ p < 0.05 and ∗∗ p < 0.01: differences from lane 2. Data were analyzed using one-way analysis of variance, followed by Tukey’s multiple comparison test. See also Figure S2 . " width="100%" height="100%">

Journal: Cell Reports

Article Title: Amelioration of SARS-CoV-2 infection by ANO6 phospholipid scramblase inhibition

doi: 10.1016/j.celrep.2022.111117

Figure Lengend Snippet: Measurements of ANO6 Ca 2+ -activated ion channel and phospholipid scramblase activities (A–C) The inhibitory effect of A6-001 on the ANO6 ion channel activity was analyzed using a whole-cell patch clamp in HEK 293T cells expressing ANO6. The pipette solution contained 10 μM free Ca 2+ . Voltage ramps spanning a range of −100 to +100 mV were delivered from a holding potential of −60 mV every 20 s (A). The current-voltage (I-V) relationships at indicated times (1–5) with increasing concentrations of A6-001 are shown in (B). The numbers in parentheses represent the time points to measure I-V relationships. The inward currents in (A) represent ANO6 tail currents. The half-maximal inhibitory concentration (IC 50 ) of A6-001 on the ANO6 ion channel activity is depicted in (C) (n = 4 at each concentration). (D–F) The effects of ANO6 inhibitors on the surface exposure of phosphatidylserine (PS) were assayed in FRT-ANO6 cells. Cells were pretreated with compounds for 10 min, before ANO6 was activated with 10 μM ionomycin. Exposed PS was stained with Lact-C2-GFP. Representative fluorescence images of A6-001 (10 μM), A6-004 (10 μM), abamectin (10 μM), and ivermectin (10 μM) are shown in (D) (scale bars: 10 μm), and fluorescence intensity values calculated from Lact-C2-GFP images are summarized in (E) (mean ± SEM; n = 6). The dose responses of A6-001 on ANO6 PS scramblase inhibition are analyzed in (F) (mean ± SEM; n = 6). Representative fluorescence images of A6-001 dose response are shown in Figure S2 H. (G and H) The inhibitory effect of A6-001 on PS scrambling was assayed using the four-quadrant dot blot FACS analysis in Jurkat cells, some of which were transfected with hANO6-expressing plasmids using a NEPA21 Super Electroporator (Jurkat-ANO6). Ionomycin evoked an increase in the Lact-C2-positive and propidium iodide (PI)-negative cell population (Q3), which represented the PS-exposed and non-apoptotic cells, respectively. The ionomycin-induced Q3 increase was augmented considerably in cells expressing exogenous ANO6. A6-001 (10 μM) reversed the Q3 increases in Jurkat and Jurkat-ANO6 cells. Representative FACS analyses are shown in (G), and a summary of the multiple experiments is presented in (H) (mean ± SEM; n = 5). ∗ p < 0.05 and ∗∗ p < 0.01: differences from lane 2. Data were analyzed using one-way analysis of variance, followed by Tukey’s multiple comparison test. See also Figure S2 .

Article Snippet: After washout, the phosphatidylserine and nuclei were stained with PBS containing 500 nM Lact-C2-GFP, then cells were washed with 200 μL PBS and microscopic images were acquired with a Lionheart FX Automated Microscope (BioTek, Winooski, VT, USA).

Techniques: Activity Assay, Patch Clamp, Expressing, Transferring, Concentration Assay, Staining, Fluorescence, Inhibition, Dot Blot, Transfection

ANO6 is responsible for phosphatidylserine externalization evoked by pseudotyped SARS-CoV-2 S virus (SARS2-PsV) HeLa cells expressing ACE2 (HeLa-ACE2) were incubated with a lentivirus-based SARS2-PsV (100 ng p24/mL; 20 MOI) or an authentic SARS-CoV-2 (10 MOI) for 15 min and then with Lact-C2-mCherry for 45 min. (A and B) Chelation of cytosolic Ca 2+ (BAPTA-AM; 10 μM; 1 h) inhibits SARS2-PsV-induced PS externalization. Representative images are shown in (A), and the quantification results of multiple experiments are summarized in (B) (n = 3, each from 3 to 5 fields per experimental condition). (C and D) Control experiments in ACE2-negative HeLa cells. PS externalization was induced by ionomycin (10 μM; 10 min). Representative images are shown in (C), and the quantification results of multiple experiments are summarized in (D) (n = 3). ns, not significant. (E and F) Silencing of ANO6 (siRNAs against ANO6; 100 nM; 24 h) inhibits the phosphatidylserine (PS) externalization evoked by SARS2-PsV. Cell nuclei were stained with DAPI. Representative images are shown in (E), and the quantification results of multiple experiments are summarized in (F) (n = 3, each from 3 to 5 fields per experimental condition). (G and H) ANO6 inhibitors (A6-001 and A6-004, each 10 μM, 1 h) inhibit SARS2-PsV-induced PS externalization. Representative images are shown in (G), and the quantification results of multiple experiments are summarized in (H) (n = 3–4). (I and J) Authentic SARS-CoV-2 virus evokes Ca 2+ - and ANO6-dependent PS externalization. The HeLa-ACE2 cells were pretreated with compounds (10 μM) for 1 h and infected with SARS-CoV-2 for 15 min. Representative images are shown in (I), and the quantification results of multiple experiments are summarized in (J) (n = 3). Bar graph data are shown as the mean ± SEM. ∗ p < 0.05 and ∗∗ p < 0.01. Data were analyzed using one-way analysis of variance, followed by Tukey’s multiple comparison test. Scale bars: 50 μm. See also <xref ref-type=Figure S3 . " width="100%" height="100%">

Journal: Cell Reports

Article Title: Amelioration of SARS-CoV-2 infection by ANO6 phospholipid scramblase inhibition

doi: 10.1016/j.celrep.2022.111117

Figure Lengend Snippet: ANO6 is responsible for phosphatidylserine externalization evoked by pseudotyped SARS-CoV-2 S virus (SARS2-PsV) HeLa cells expressing ACE2 (HeLa-ACE2) were incubated with a lentivirus-based SARS2-PsV (100 ng p24/mL; 20 MOI) or an authentic SARS-CoV-2 (10 MOI) for 15 min and then with Lact-C2-mCherry for 45 min. (A and B) Chelation of cytosolic Ca 2+ (BAPTA-AM; 10 μM; 1 h) inhibits SARS2-PsV-induced PS externalization. Representative images are shown in (A), and the quantification results of multiple experiments are summarized in (B) (n = 3, each from 3 to 5 fields per experimental condition). (C and D) Control experiments in ACE2-negative HeLa cells. PS externalization was induced by ionomycin (10 μM; 10 min). Representative images are shown in (C), and the quantification results of multiple experiments are summarized in (D) (n = 3). ns, not significant. (E and F) Silencing of ANO6 (siRNAs against ANO6; 100 nM; 24 h) inhibits the phosphatidylserine (PS) externalization evoked by SARS2-PsV. Cell nuclei were stained with DAPI. Representative images are shown in (E), and the quantification results of multiple experiments are summarized in (F) (n = 3, each from 3 to 5 fields per experimental condition). (G and H) ANO6 inhibitors (A6-001 and A6-004, each 10 μM, 1 h) inhibit SARS2-PsV-induced PS externalization. Representative images are shown in (G), and the quantification results of multiple experiments are summarized in (H) (n = 3–4). (I and J) Authentic SARS-CoV-2 virus evokes Ca 2+ - and ANO6-dependent PS externalization. The HeLa-ACE2 cells were pretreated with compounds (10 μM) for 1 h and infected with SARS-CoV-2 for 15 min. Representative images are shown in (I), and the quantification results of multiple experiments are summarized in (J) (n = 3). Bar graph data are shown as the mean ± SEM. ∗ p < 0.05 and ∗∗ p < 0.01. Data were analyzed using one-way analysis of variance, followed by Tukey’s multiple comparison test. Scale bars: 50 μm. See also Figure S3 .

Article Snippet: After washout, the phosphatidylserine and nuclei were stained with PBS containing 500 nM Lact-C2-GFP, then cells were washed with 200 μL PBS and microscopic images were acquired with a Lionheart FX Automated Microscope (BioTek, Winooski, VT, USA).

Techniques: Expressing, Incubation, Staining, Infection

Journal: Cell Reports

Article Title: Amelioration of SARS-CoV-2 infection by ANO6 phospholipid scramblase inhibition

doi: 10.1016/j.celrep.2022.111117

Figure Lengend Snippet:

Article Snippet: After washout, the phosphatidylserine and nuclei were stained with PBS containing 500 nM Lact-C2-GFP, then cells were washed with 200 μL PBS and microscopic images were acquired with a Lionheart FX Automated Microscope (BioTek, Winooski, VT, USA).

Techniques: Recombinant, Modification, Cell Culture, Protease Inhibitor, Protein Purification, Fluorescence, Plasmid Preparation, Bicinchoninic Acid Protein Assay, Proliferation Assay, CCK-8 Assay, Luciferase, Software, Microscopy, Laser-Scanning Microscopy, Patch Clamp